-
Mashup Score: 2Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 1 - 6 hour(s) ago
A 5-expert panel delves into atopic dermatitis guidelines and recommendations and recent studies to make note of.
Source: www.dermatologytimes.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 0Children's food allergy: Effects of environmental influences and antibiotic use across critical developmental windows - 8 hour(s) ago
“A blog about allergy, asthma & immunology”
Source: ivancevichmd.blogspot.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 0A TH17-intrinsic IL-1β–STAT5 axis drives steroid resistance in autoimmune neuroinflammation - 8 hour(s) ago
IL-1β mediates steroid resistance in TH17 cells via a STAT5-dependent mechanism during autoimmune CNS inflammation.
Source: www.science.orgCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 9Antigen-level resolution of commensal-specific B cell responses can be enabled by phage display screening coupled with B cell tetramers - 9 hour(s) ago
Adaptive immunity to commensal microbes promotes tissue homeostasis, immunity, and repair, but approaches to identify commensal-specific B cell responses are lacking. Verma et al. utilize phage display screening and subsequent generation of B cell tetramers to identify anatomical compartmentalization of SFB-specific B cell responses in gut-associated lymphoid tissues.
Source: www.cell.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 0
Interim trial results show that the only clinical-stage nondepleting anti-OX40 mAb provided rapid skin sign improvement in atopic dermatitis.
Categories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 8
20% of patients treated with Rinvoq achieved 90% or greater reduction on the Eczema Area and Severity Index (EASI) and attained a 0 or 1 grade on the Worst Pruritis Numerical Rating Scale (WP-NRS) compared to 9% of patients treated with Dupixent. The rate of serious adverse events was 0.9% for both Rinvoq and Dupixent.
Source: www.2minutemedicine.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 7Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 1 - 11 hour(s) ago
A 5-expert panel delves into atopic dermatitis guidelines and recommendations and recent studies to make note of.
Source: www.dermatologytimes.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 0High-Throughput Antigen Microarray Identifies Longitudinal Prognostic Autoantibody for Chemoimmunotherapy in Advanced Non-Small Cell Lung Cancer - 15 hour(s) ago
In BriefThis study screens 21,000 autoantibodies in aNSCLC patients undergoing ICIs monotherapy and chemoimmunotherapy, identifying prognostic markers—MAX, DHX29, and TAPBP AAbs—for early progression and progression-free survival. This systematic approach involves de novo screening, identification, and validation, providing clinical potential to monitor chemoimmunotherapy efficacy and detect disease progression.
Source: www.mcponline.orgCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 0Increasing funding means more health care when you need it. - 1 day(s) ago
Stand with Ontario’s Doctors
Source: fundhealthcare.caCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 0
Stand with Ontario’s Doctors
Source: fundhealthcare.caCategories: General Medicine News, Allergy-ImmunologyTweet
Insights from advanced research and clinical viewpoints on improving treatments for #Atopic #Dermatitis. Stay informed with the latest studies. #Dermatology #SkinHealth https://t.co/GfTFo48N5S https://t.co/NcYraMgf3b